CONTENT
What is Swine flu?
Symptoms of Swine flu?
Mode of Transmission ?
Period of Communicability?
Incubation Period?
Prevention of Swine flu
TAKE HOME MESSAGE
WHAT IS SWINE FLU?
It is a respiratory disease caused by H1 N1
Type A Influenza Virus.
It is like ordinary flu.
The Swine flu was initially seen in humans in
Mexico in 2009, where the strand of the
particular virus was a marriage of 3 types of
strands.
WHAT IS SWINE FLU?
The major reason of its world wide spread is
the lack of immunity against the virus in a
large population.
WHO declares swine flu as pandemic on 11
June 2009.
Mode of Transmission?
Cough and Sneezing by Infected Indl
Virus deposited on any Surface
Healthy indl touches the contaminated surface
Healthy Indl touches his Eyes, Nose or Mouth
Healthy Indl becomes infected
High Risk Group
Children with mild illness
but with predisposing risk factors.
Pregnant women;
Persons aged 65 years or older;
Patients with lung diseases,
heart disease, liver disease, kidney disease, blood
disorders, diabetes, neurological disorders, cancer and
HIV/AIDS;
Patients on long term cortisone therapy.
Warning Signals in Adults ?
Breathlessness,
chest pain,
drowsiness,
fall in blood pressure,
sputum mixed with blood,
bluish discolouration of nails;
Confusion
Warning Signals in Children
(Red Flag Signs) ?
Somnolence,
high and persistent fever,
inability to feed well,
convulsions,
shortness of breath,
difficulty in breathing,
Inconsolable cry, etc.
Prevention and control
In order to prevent and contain outbreak of
Influenza virus the following guidelines for
screening, testing and isolation are to be followed:
At first all individuals seeking consultations for flu
like symptoms should be screened at healthcare
facilities both Government and private or examined
by a doctor and these will be categorized as under:
Category A
Patients with mild fever plus cough / sore throat
with or without bodyache, headache, diarrhoea and
vomiting will be categorized as Category-A.
They do not require Oseltamivir and should be
treated for the symptoms mentioned above. The
patients should be monitored for their progress and
reassessed at 24 to 48 hours by the doctor.
No testing of the patient for Influenza is required.
Patients should confine themselves at home and
avoid mixing up with public and high risk members
in the family.
Category B
(i) In addition to all the signs and symptoms
mentioned under Category-A, if the patient has high
grade fever and severe sore throat, may require
home isolation and Oseltamivir;
(ii) In addition to all the signs and symptoms
mentioned under Category-A, individuals having
one or more of the following high risk conditions
shall be treated with Oseltamivir:
Category B
Children with mild illness but with predisposing risk
factors.
Pregnant women;
Persons aged 65 years or older;
Patients with lung diseases, heart disease, liver
disease, kidney disease, blood disorders, diabetes,
neurological disorders, cancer and HIV/AIDS;
Patients on long term cortisone therapy
Category B
No tests for Influenza is required for Category-B (i)
and (ii).
All patients of Category-B (i) and (ii) should confine
themselves at home and avoid mixing with public
and high risk members in the family.
Broad Spectrum antibiotics as per the Guideline for
Community-acquired pneumonia (CAP) may be
prescribed.
Category C
In addition to the above signs and symptoms of
Category-A and B, if the patient has one or more of
the following:
Breathlessness, chest pain, drowsiness, fall in blood
pressure, sputum mixed with blood, bluish
discolouration of nails;
Category C
Children with influenza like illness who had a severe
disease as manifested by the red flag signs
(Somnolence, high and persistent fever, inability to
feed well, convulsions, shortness of breath,
difficulty in breathing, etc).
Worsening of underlying chronic conditions.
All these patients mentioned above in Category-C
require testing, immediate hospitalization and
treatment.
रोकथाम के उपाय
क्या करैं
१. ख ांसते य छ ांकते समय अपने
मांह व न क को टिश्यू य रूम ल से
कवर करैं |
२. अपनी आांख, न क य मांह को
छू ने से पहले ह थों को अच्छ तरह
स बन से धोयें |
३. बीम र व्यक्तत से दूरी बन ये
रखें |
४. कोई भी तकलीफ होने पर
डॉतिर की सल ह अवश्य लें |
५. खूब प नी पीयें, पोषक भोजन
ख यें और भरपूर नीांद लें |
क्या नह ीं करैं
१.ह थ ममल ने, गले ममलने और
चम्बन लेने से बचें |
२. भीड़ व ले स्थ नों पर ज ने से
बचें |
३. फ्लू रोगी के अधधक ननकि न
ज यें |
४. जह ाँ तक हो सके अपनी आाँख,
न क य मांह को न छयें |
५. अपने ह थों पर ख ांसे य छ कें
नहीां
६. ड तिर की सल ह के बबन
कोई दव ई न लें |
Vaccine
While declaring the Pandemic to be over in August
2010, WHO conveyed that Pandemic Influenza A
(HINI) virus that caused Pandemic [2009-2010]
would circulate as Seasonal Influenza virus and
would continue to do so for years to come.
WHO recommended vaccine only for High Risk Group
Ministry of Health and Family Welfare recommends
the trivalent inactivated influenza vaccine.
Vaccine
The ICMR has recommended on the following
Seasonal Influenza vaccine composition, for the
period 2017-2018. The recommended Trivalent
vaccine should have:
an A/Michigan/45/2015 (H1N1)pdm09-like virus
an A/Hong Kong/4801/2014 (H3N2) – like virus
a B/Brisbane/60/2008-like virus
Vaccine
The available vaccine takes about 2-3 weeks for
development of immunity. Hence for the health care
workers working in an environment with likelihood of
exposure to Influenza virus, vaccine should be
administered at least one month prior to the
commencement of the season, till such time use of
chemoprophylaxis may be considered.
Vaccine
The available vaccine takes about 2-3 weeks for
development of immunity. Hence for the health care
workers working in an environment with likelihood of
exposure to Influenza virus, vaccine should be
administered at least one month prior to the
commencement of the season, till such time use of
chemoprophylaxis may be considered.
Limitations of the Influenza
Vaccination
Influenza vaccination is most effective when
circulating viruses are well-matched with vaccine
viruses.
Even with appropriate matching, efficacy of vaccine
may be about 70% to 80%.
In case the locally circulating virus is different from
vaccine virus recommended by WHO, it may be
partially effective or not be effective at all.
Hence, vaccine should not give a false sense of
security.
High Risk Groups for whom
vaccine is recommended by WHO
Health Care workers, working in hospital / institutional
settings (doctors, nurses, paramedics) with likelihood
of exposure to Influenza virus
Young children
Pregnant women;
Persons aged 65 years or older;
Patients with Comorbidity
Patients with compromised immunity
USE OF MASKS
There are two types of masks which are recommended
for various categories of personnel depending upon the
work environment;
1. Triple layer surgical mask 2. N 95 Respirator
Change the mask after six hours or as soon as they
become wet.
Disposable masks are never to be reused and should be
disposed off.
Never touch the potentially infected outer surface of
the mask while removing it.
USE OF MASKS
There is no scientific evidence to show health benefit of
using masks for members of public. In fact erroneous
use of masks or continuous use of a disposable mask
for longer than 6 hours or repeated use of same mask
may actually increase risk of infection further.
In the hospital setting used masks should be disposed
off in the identified infectious waste disposal
bag/container.
In community settings, it may be disposed off either by
burning or deep burial.
Triple layer surgical mask
Suspect/ probable/confirmed cases of influenza.
The care provider in home care settings
Close family contacts of such cases undergoing home
care should also use Triple layer surgical mask.
All medical personnel (Doctor, nursing and paramedical
staff) would use Disposable Triple layer surgical mask
while interacting with patients in screening area.
All patients, Medical and nursing staff in the isolation
wards.
Triple layer surgical mask
Personnel involved in handling dead bodies of
suspect/confirmed cases (Mortuary)
Ambulance Staff including driver.
Doctors /Private practitioners with other health
workers in screening centres / general practice
Health workers involved in community surveillance
Security personnel working in an infected/ potentially
infected area for example Influenza ward in a hospital,
screening centre etc.
N 95 Respirator
Staff involved in any aerosol generating procedures
like suction, intubation, nebulization, etc. they must
use N95 Respirator
Medical personnel need to collect clinical samples from
patients.
Medical personnel in ICU
Medical personnel in laboratory
Tamiflu (Oseltamivir)
Oseltamivir is the recommended drug for treatment.
Dose for treatment is as follows -
By Weight:
o For weight <15kg 30 mg BD for 5 days
o 15-23kg 45 mg BD for 5 days
o 24-<40kg 60 mg BD for 5 days
o >40kg 75 mg BD for 5 days
Tamiflu (Oseltamivir)
For infants:
o < 3 months 12 mg BD for 5 days
o 3-5 months 20 mg BD for 5 days
o 6-11 months 25 mg BD for 5 days
It is also available as syrup (12mg per ml)
Q 1. SWINE FLU IS CAUSED BY ?
A. BACTERIA
B. VIRUS
C. (FUNGUS
D. CONTAMINATED WATER
Q5. What are the preventive
measures of Swine flu ?
A. Cover your cough and sneeze.
B. Wash your hands at regular interval.
C. Avoid touching your eye, nose and mouth
unnecessarily.
D. Keep safe distance from an infected
individual.
E. All of the above.
Q5. What are the preventive
measures of Swine flu ?
E. All of the above
Triple Layer Surgical Mask- Tie on Mask of Non-woven, Hypoallergenic 3 ply construction with filter in between offering >99 percent standard with 4 tie strings.
N-95 Respirator Mask - Filter efficiency of 95 % or more against particulate aerosols. The mask should be provided with expiration valve. It should be disposable & to be able to fit for wide range of face sizes. It should accompany with certification from NIOSH (National Institute for Occupational Safety and Health) or any other internationally accepted certification.